Literature DB >> 5926092

Disquisitions on Original Antigenic Sin. II. Proof in lower creatures.

R G Webster.   

Abstract

Experiments in rabbits were designed to test the two unproven assumptions of the hypothesis proposed in the companion paper (1): that Original Antigenic Sin is fundamentally a restricted anamnestic response, and that there exists a trapping mechanism capable of deflecting antigen from one kind of cell and guiding it to another. It is shown that whole-body X-irradiation, sufficient to abolish primary but not secondary production of antibodies, leaves all manifestations of the Original Antigenic Sin untouched. This proves the first assumption. Primary immune animals challenged with very large doses of a related antigen produce an immediate response of cross-reactive antibodies, followed by a standard primary response to the challenging antigen. When boosted with an appropriate mixture of both antigens, the response is of standard secondary type to the homologous antigen, followed by a standard primary response to the crossreacting antigen. When animals are primarily vaccinated with a mixture of two related antigens, small booster doses of either will stimulate a standard secondary response only. When such animals are given very large booster doses of either antigen, the response is a compound of a homologous secondary and of an Original Antigenic Sin-type against the related antigen. Each of these findings demonstrates a corollary of the second assumption. The results are discussed in terms of the limitations they impose on theories concerned with the production of antibodies.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5926092      PMCID: PMC2138229          DOI: 10.1084/jem.124.3.347

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  6 in total

1.  Studies of antibodies to strains of influenza virus in persons of different ages in sera collected in a postepidemic period.

Authors:  A V HENNESSY; F M DAVENPORT; T FRANCIS
Journal:  J Immunol       Date:  1955-11       Impact factor: 5.422

2.  Characterization of influenza antibodies by serum absorption.

Authors:  K E JENSEN; F M DAVENPORT; A V HENNESSY; T FRANCIS
Journal:  J Exp Med       Date:  1956-08-01       Impact factor: 14.307

3.  Predetermination by infection and by vaccination of antibody response to influenza virus vaccines.

Authors:  F M DAVENPORT; A V HENNESSY
Journal:  J Exp Med       Date:  1957-12-01       Impact factor: 14.307

4.  A serologic recapitulation of past experiences with influenza A; antibody response to monovalent vaccine.

Authors:  F M DAVENPORT; A V HENNESSY
Journal:  J Exp Med       Date:  1956-07-01       Impact factor: 14.307

5.  Disquisitions of Original Antigenic Sin. I. Evidence in man.

Authors:  R G Webster
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

6.  Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus.

Authors:  F M DAVENPORT; A V HENNESSY; T FRANCIS
Journal:  J Exp Med       Date:  1953-12       Impact factor: 14.307

  6 in total
  76 in total

1.  Variable efficacy of repeated annual influenza vaccination.

Authors:  D J Smith; S Forrest; D H Ackley; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 2.  Mechanisms of immune escape in viral hepatitis.

Authors:  W Rosenberg
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

3.  A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants.

Authors:  Wilfred Ndifon
Journal:  J R Soc Interface       Date:  2015-11-06       Impact factor: 4.118

Review 4.  Immune history and influenza virus susceptibility.

Authors:  Sarah Cobey; Scott E Hensley
Journal:  Curr Opin Virol       Date:  2017-01-12       Impact factor: 7.090

5.  Antigenic distance measurements for seasonal influenza vaccine selection.

Authors:  Zhipeng Cai; Tong Zhang; Xiu-Feng Wan
Journal:  Vaccine       Date:  2011-11-07       Impact factor: 3.641

6.  A discrete computer model of the immune system reveals competitive interactions between the humoral and cellular branch and between cross-reacting memory and naïve responses.

Authors:  Yiming Cheng; Dario Ghersi; Claudia Calcagno; Liisa K Selin; Roberto Puzone; Franco Celada
Journal:  Vaccine       Date:  2008-12-25       Impact factor: 3.641

Review 7.  A vaccine for HIV type 1: the antibody perspective.

Authors:  D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

8.  Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for sero-diagnosis of leprosy.

Authors:  R Melsom; M Harboe; B Myrvang; T Godal; A Belehu
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

9.  Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.

Authors:  Danuta M Skowronski; Gaston De Serres; Natasha S Crowcroft; Naveed Z Janjua; Nicole Boulianne; Travis S Hottes; Laura C Rosella; James A Dickinson; Rodica Gilca; Pam Sethi; Najwa Ouhoummane; Donald J Willison; Isabelle Rouleau; Martin Petric; Kevin Fonseca; Steven J Drews; Anuradha Rebbapragada; Hugues Charest; Marie-Eve Hamelin; Guy Boivin; Jennifer L Gardy; Yan Li; Trijntje L Kwindt; David M Patrick; Robert C Brunham
Journal:  PLoS Med       Date:  2010-04-06       Impact factor: 11.069

10.  Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials.

Authors:  Scott A Brown; Sherri L Surman; Robert Sealy; Bart G Jones; Karen S Slobod; Kristen Branum; Timothy D Lockey; Nanna Howlett; Pamela Freiden; Patricia Flynn; Julia L Hurwitz
Journal:  Viruses       Date:  2010-02-01       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.